These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32948541)

  • 41. Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
    McCool R; Gould IM; Eales J; Barata T; Arber M; Fleetwood K; Glanville J; Kauf TL
    BMC Infect Dis; 2017 Jan; 17(1):39. PubMed ID: 28061827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Role of Non-genetic Therapies to Reduce the Incidence of Sickle Cell Crisis: A Systematic Review.
    Pingili S; Makkena VK; Jaramillo AP; Awosusi BL; Ayyub J; Dabhi KN; Gohil NV; Tanveer N; Hussein S; Hamid P
    Cureus; 2023 Aug; 15(8):e42785. PubMed ID: 37664256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. l-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope?
    Leibovitch JN; Tambe AV; Cimpeanu E; Poplawska M; Jafri F; Dutta D; Lim SH
    Blood Rev; 2022 May; 53():100925. PubMed ID: 34991920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent
    Alhifany AA; Almutairi AR; Almangour TA; Shahbar AN; Abraham I; Alessa M; Alnezary FS; Cheema E
    BMJ Open; 2019 Nov; 9(11):e031145. PubMed ID: 31699731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P-Selectin Blockade in the Treatment of Painful Vaso-Occlusive Crises in Sickle Cell Disease: A Spotlight on Crizanlizumab.
    Karki NR; Kutlar A
    J Pain Res; 2021; 14():849-856. PubMed ID: 33833562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.
    Sarray S; Saleh LR; Lisa Saldanha F; Al-Habboubi HH; Mahdi N; Almawi WY
    Cytokine; 2015 Mar; 72(1):43-7. PubMed ID: 25569375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis.
    Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Millis RM
    Hematology; 2003 Dec; 8(6):421-8. PubMed ID: 14668039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Real-World Data of Crizanlizumab in Sickle Cell Disease: A Single-Center Analysis.
    Cheplowitz H; Block S; Groesbeck J; Sacknoff S; Nguyen AL; Gopal S
    J Hematol; 2023 Jun; 12(3):105-108. PubMed ID: 37435415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relative performance of brivaracetam as adjunctive treatment of focal seizures in adults: a network meta-analysis.
    Charokopou M; Harvey R; Srivastava K; Brandt C; Borghs S
    Curr Med Res Opin; 2019 Aug; 35(8):1345-1354. PubMed ID: 30799639
    [No Abstract]   [Full Text] [Related]  

  • 50. Two drugs for sickle cell disease.
    Med Lett Drugs Ther; 2020 Apr; 62(1595):51-52. PubMed ID: 32324178
    [No Abstract]   [Full Text] [Related]  

  • 51. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
    van Zuuren EJ; Fedorowicz Z
    Cochrane Database Syst Rev; 2013 Jun; (6):CD010155. PubMed ID: 23760785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of diclofenac in osteoarthritis: Results of a network meta-analysis of unpublished legacy studies.
    Guyot P; Pandhi S; Nixon RM; Iqbal A; Chaves RL; Andrew Moore R
    Scand J Pain; 2017 Jul; 16():74-88. PubMed ID: 28850416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis.
    Snedecor SJ; Radford M; Kratochvil D; Grove R; Punekar YS
    BMC Infect Dis; 2019 May; 19(1):484. PubMed ID: 31146698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incorporation of novel therapies for the management of sickle cell disease: A pharmacist's perspective.
    Dela-Pena JC; King MA; Brown J; Nachar VR
    J Oncol Pharm Pract; 2022 Apr; 28(3):646-663. PubMed ID: 35060419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults.
    Bartolucci P; El Murr T; Roudot-Thoraval F; Habibi A; Santin A; Renaud B; Noël V; Michel M; Bachir D; Galactéros F; Godeau B
    Blood; 2009 Oct; 114(18):3742-7. PubMed ID: 19717646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conjunctival microvascular hemodynamics following vaso-occlusive crisis in sickle cell disease.
    Kord Valeshabad A; Wanek J; Gaynes B; Saraf SL; Molokie R; Shahidi M
    Clin Hemorheol Microcirc; 2015 Sep; 62(4):359-67. PubMed ID: 26444608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Evolving Landscape of Drug Therapies for Sickle Cell Disease.
    Rai P; Desai PC; Ataga KI
    Hematol Oncol Clin North Am; 2022 Dec; 36(6):1285-1312. PubMed ID: 36400544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3).
    Heeney MM; Abboud MR; Amilon C; Andersson M; Githanga J; Inusa B; Kanter J; Leonsson-Zachrisson M; Michelson AD; Berggren AR;
    Contemp Clin Trials; 2019 Oct; 85():105835. PubMed ID: 31446143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
    Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
    Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.